Related references
Note: Only part of the references are listed.Epigenetic Regulation and Promising Therapies in Colorectal Cancer
Chandra Kishore
CURRENT MOLECULAR PHARMACOLOGY (2021)
Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer
Chai-Jin Lee et al.
BMC MEDICAL GENOMICS (2020)
Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer
Zahra Montazeri et al.
GUT (2020)
miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study
Elena Milanesi et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
The Suppressing Effects of Dkk3 Expression on Aggressiveness and Tumorigenesis of Colorectal Cancer
Shuang Zhao et al.
FRONTIERS IN ONCOLOGY (2020)
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
Tim C. de Ruijter et al.
BREAST CANCER RESEARCH (2020)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights
Francesco Caputo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Long interspersed nucleotide element-1 (LINE-1) methylation in colorectal cancer
Mohammad Amin Kerachian et al.
CLINICA CHIMICA ACTA (2019)
DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients
Xinyan Liu et al.
BMC CANCER (2019)
The role of epigenetic therapies in colorectal cancer
Marina Baretti et al.
CURRENT PROBLEMS IN CANCER (2018)
The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy
Ha Thi Nguyen et al.
ONCOLOGY LETTERS (2018)
Epigenetic inactivation of RUNX3 in colorectal cancer
Eung Jin Shin et al.
ANNALS OF SURGICAL TREATMENT AND RESEARCH (2018)
Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer
Barbara Jung et al.
GASTROENTEROLOGY (2017)
Hypomethylating agents synergize with irinotecan to improve response to chemotherapy in colorectal cancer cells
Anup Sharma et al.
PLOS ONE (2017)
Clinical significance of PCDH10 promoter methylation in diffuse large B-cell lymphoma
Wenting Huang et al.
BMC CANCER (2017)
Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?
Janson W. T. Tse et al.
TRENDS IN CANCER (2017)
DNA methylation based biomarkers in colorectal cancer: A systematic review
Kevin Lam et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients
Binnur Bagci et al.
CANCER BIOMARKERS (2016)
The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription
Wael M. Abdel-Rahman et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Molecular pathogenesis of sporadic colorectal cancers
Hidetsugu Yamagishi et al.
CHINESE JOURNAL OF CANCER (2016)
Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas
Arpad V. Patai et al.
PLOS ONE (2015)
Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer
Nader Mansour Samaei et al.
JOURNAL OF BIOMEDICAL SCIENCE (2014)
Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
Quirinus J. M. Voorham et al.
BMC CANCER (2013)
Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
Muling Mao et al.
CLINICAL CANCER RESEARCH (2013)
PCDH10 Promoter Hypermethylation is Frequent in most Histologic Subtypes of Mature Lymphoid Malignancies and Occurs Early in Lymphomagenesis
Gopeshwar Narayan et al.
GENES CHROMOSOMES & CANCER (2013)
Frequent epigenetic silencing of PCDH10 by methylation in human colorectal cancer
Xian Zhong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Epigenetic Reprogramming in Cancer
Mario L. Suva et al.
SCIENCE (2013)
DNA methylation as an epigenetic biomarker in colorectal cancer
Tiago Donizetti Silva et al.
ONCOLOGY LETTERS (2013)
PCDH10 is a candidate tumour suppressor gene in medulloblastoma
Kelsey C. Bertrand et al.
CHILDS NERVOUS SYSTEM (2011)
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
Francesco Crea et al.
DRUG RESISTANCE UPDATES (2011)
Novel Application of Structural Equation Modeling to Correlation Structure Analysis of CpG Island Methylation in Colorectal Cancer
Noriko Tanaka et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
Victoria Gonzalo et al.
PLOS ONE (2010)
Function and biological roles of the Dickkopf family of Wnt modulators
C. Niehrs
ONCOGENE (2006)
DNA methylation: past, present and future directions
KD Robertson et al.
CARCINOGENESIS (2000)
Share Paper
